Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
Mammalian cell defence mechanisms against the cytotoxicity of NaYF.

Nanoscale

Sikora B, Kowalik P, Mikulski J, Fronc K, Kamińska I, Szewczyk M, Konopka A, Zajdel K, Minikayev R, Sobczak K, Zaleszczyk W, Borodziuk A, Rybusiński J, Szczytko J, Sienkiewicz A, Wojciechowski T, Stępień P, Frontczak-Baniewicz M, Łapiński M, Wilczyński G, Paszkowicz W, Twardowski A, Elbaum D.
PMID: 28914943
Nanoscale. 2017 Sep 28;9(37):14259-14271. doi: 10.1039/c7nr03705h.

Water-soluble upconversion nanoparticles (UCNPs), based on polyvinylpyrrolidone (PVP)-coated NaYF

Cite
Sikora B, Kowalik P, Mikulski J, et al. Mammalian cell defence mechanisms against the cytotoxicity of NaYF. Nanoscale. 2017;9(37):14259-14271doi: 10.1039/c7nr03705h.
Sikora, B., Kowalik, P., Mikulski, J., Fronc, K., Kamińska, I., Szewczyk, M., Konopka, A., Zajdel, K., Minikayev, R., Sobczak, K., Zaleszczyk, W., Borodziuk, A., Rybusiński, J., Szczytko, J., Sienkiewicz, A., Wojciechowski, T., Stępień, P., Frontczak-Baniewicz, M., Łapiński, M., Wilczyński, G., Paszkowicz, W., Twardowski, A., & Elbaum, D. (2017). Mammalian cell defence mechanisms against the cytotoxicity of NaYF. Nanoscale, 9(37), 14259-14271. https://doi.org/10.1039/c7nr03705h
Sikora, B, et al. "Mammalian cell defence mechanisms against the cytotoxicity of NaYF." Nanoscale vol. 9,37 (2017): 14259-14271. doi: https://doi.org/10.1039/c7nr03705h
Sikora B, Kowalik P, Mikulski J, Fronc K, Kamińska I, Szewczyk M, Konopka A, Zajdel K, Minikayev R, Sobczak K, Zaleszczyk W, Borodziuk A, Rybusiński J, Szczytko J, Sienkiewicz A, Wojciechowski T, Stępień P, Frontczak-Baniewicz M, Łapiński M, Wilczyński G, Paszkowicz W, Twardowski A, Elbaum D. Mammalian cell defence mechanisms against the cytotoxicity of NaYF. Nanoscale. 2017 Sep 28;9(37):14259-14271. doi: 10.1039/c7nr03705h. PMID: 28914943.
Copy Download .nbib Format: NLM
Editorial.

Klinische Monatsblatter fur Augenheilkunde

Goldblum D.
PMID: 28470641
Klin Monbl Augenheilkd. 2017 Apr;234(4):418. doi: 10.1055/s-0043-104918. Epub 2017 May 03.

No abstract available.

Cite
Goldblum D. Editorial. Editorial. Klin Monbl Augenheilkd. 2017;234(4):418doi: 10.1055/s-0043-104918.
Goldblum, D. (2017). Editorial. Editorial. Klinische Monatsblatter fur Augenheilkunde, 234(4), 418. https://doi.org/10.1055/s-0043-104918
Goldblum, D. "Editorial." Editorial. Klinische Monatsblatter fur Augenheilkunde vol. 234,4 (2017): 418. doi: https://doi.org/10.1055/s-0043-104918
Goldblum D. Editorial. Editorial. Klin Monbl Augenheilkd. 2017 Apr;234(4):418. doi: 10.1055/s-0043-104918. Epub 2017 May 03. PMID: 28470641.
Copy Download .nbib Format: NLM
Analysis of opacification patterns in intraocular lenses (IOL).

BMJ open ophthalmology

Mackert M, Muth DR, Vounotrypidis E, Deger C, Goldblum D, Shajari M, Hasler PW, Priglinger S, Wolf A.
PMID: 33634210
BMJ Open Ophthalmol. 2021 Feb 11;6(1):e000589. doi: 10.1136/bmjophth-2020-000589. eCollection 2021.

OBJECTIVE: Intraocular lens (IOL) opacification may cause severe visual impairment. The pathogenesis remains unclear. The aim of this study was to analyse opacification patterns in different IOLs. Therefore, this multicentre, retrospective, observational study was conducted at Ludwig-Maximilians-University, Munich, Germany...

Cite
Mackert M, Muth DR, Vounotrypidis E, et al. Analysis of opacification patterns in intraocular lenses (IOL). BMJ Open Ophthalmol. 2021;6(1):e000589doi: 10.1136/bmjophth-2020-000589.
Mackert, M., Muth, D. R., Vounotrypidis, E., Deger, C., Goldblum, D., Shajari, M., Hasler, P. W., Priglinger, S., & Wolf, A. (2021). Analysis of opacification patterns in intraocular lenses (IOL). BMJ open ophthalmology, 6(1), e000589. https://doi.org/10.1136/bmjophth-2020-000589
Mackert, Marc, et al. "Analysis of opacification patterns in intraocular lenses (IOL)." BMJ open ophthalmology vol. 6,1 (2021): e000589. doi: https://doi.org/10.1136/bmjophth-2020-000589
Mackert M, Muth DR, Vounotrypidis E, Deger C, Goldblum D, Shajari M, Hasler PW, Priglinger S, Wolf A. Analysis of opacification patterns in intraocular lenses (IOL). BMJ Open Ophthalmol. 2021 Feb 11;6(1):e000589. doi: 10.1136/bmjophth-2020-000589. eCollection 2021. PMID: 33634210; PMCID: PMC7880112.
Copy Download .nbib Format: NLM
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Thor M, Shepherd AF, Preeshagul I, Offin M, Gelblum DY, Wu AJ, Apte A, Simone CB, Hellmann MD, Rimner A, Chaft JE, Gomez DR, Deasy JO, Shaverdian N.
PMID: 34942280
Radiother Oncol. 2021 Dec 20;167:158-164. doi: 10.1016/j.radonc.2021.12.016. Epub 2021 Dec 20.

BACKGROUND: The impact of peripheral blood immune measures and radiation-induced lymphopenia on outcomes in non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiation (cCRT) and immune check point inhibition (ICI) has yet to be fully defined.METHODS: Stage III...

Cite
Thor M, Shepherd AF, Preeshagul I, et al. Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab. Radiother Oncol. 2021;167:158-164doi: 10.1016/j.radonc.2021.12.016.
Thor, M., Shepherd, A. F., Preeshagul, I., Offin, M., Gelblum, D. Y., Wu, A. J., Apte, A., Simone, C. B., Hellmann, M. D., Rimner, A., Chaft, J. E., Gomez, D. R., Deasy, J. O., & Shaverdian, N. (2021). Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 167158-164. https://doi.org/10.1016/j.radonc.2021.12.016
Thor, Maria, et al. "Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 167 (2021): 158-164. doi: https://doi.org/10.1016/j.radonc.2021.12.016
Thor M, Shepherd AF, Preeshagul I, Offin M, Gelblum DY, Wu AJ, Apte A, Simone CB, Hellmann MD, Rimner A, Chaft JE, Gomez DR, Deasy JO, Shaverdian N. Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab. Radiother Oncol. 2021 Dec 20;167:158-164. doi: 10.1016/j.radonc.2021.12.016. Epub 2021 Dec 20. PMID: 34942280.
Copy Download .nbib Format: NLM
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Thor M, Shepherd AF, Preeshagul I, Offin M, Gelblum DY, Wu AJ, Apte A, Simone CB, Hellmann MD, Rimner A, Chaft JE, Gomez DR, Deasy JO, Shaverdian N.
PMID: 34942280
Radiother Oncol. 2021 Dec 20; doi: 10.1016/j.radonc.2021.12.016. Epub 2021 Dec 20.

BACKGROUND: The impact of peripheral blood immune measures and radiation-induced lymphopenia on outcomes in non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiation (cCRT) and immune check point inhibition (ICI) has yet to be fully defined.METHODS: Stage III...

Cite
Thor M, Shepherd AF, Preeshagul I, et al. Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab. Radiother Oncol. 2021;doi: 10.1016/j.radonc.2021.12.016.
Thor, M., Shepherd, A. F., Preeshagul, I., Offin, M., Gelblum, D. Y., Wu, A. J., Apte, A., Simone, C. B., Hellmann, M. D., Rimner, A., Chaft, J. E., Gomez, D. R., Deasy, J. O., & Shaverdian, N. (2021). Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, . https://doi.org/10.1016/j.radonc.2021.12.016
Thor, Maria, et al. "Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. (2021). doi: https://doi.org/10.1016/j.radonc.2021.12.016
Thor M, Shepherd AF, Preeshagul I, Offin M, Gelblum DY, Wu AJ, Apte A, Simone CB, Hellmann MD, Rimner A, Chaft JE, Gomez DR, Deasy JO, Shaverdian N. Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab. Radiother Oncol. 2021 Dec 20; doi: 10.1016/j.radonc.2021.12.016. Epub 2021 Dec 20. PMID: 34942280.
Copy Download .nbib Format: NLM
Editorial.

Klinische Monatsblatter fur Augenheilkunde

Goldblum D.
PMID: 32330976
Klin Monbl Augenheilkd. 2020 Apr;237(4):387. doi: 10.1055/a-1024-5061. Epub 2020 Apr 24.

No abstract available.

Cite
Goldblum D. Editorial. Editorial. Klin Monbl Augenheilkd. 2020;237(4):387doi: 10.1055/a-1024-5061.
Goldblum, D. (2020). Editorial. Editorial. Klinische Monatsblatter fur Augenheilkunde, 237(4), 387. https://doi.org/10.1055/a-1024-5061
Goldblum, David. "Editorial." Editorial. Klinische Monatsblatter fur Augenheilkunde vol. 237,4 (2020): 387. doi: https://doi.org/10.1055/a-1024-5061
Goldblum D. Editorial. Editorial. Klin Monbl Augenheilkd. 2020 Apr;237(4):387. doi: 10.1055/a-1024-5061. Epub 2020 Apr 24. PMID: 32330976.
Copy Download .nbib Format: NLM
A Review and Analysis of Managing Commonly Seen Implanted Devices for Patients Undergoing Radiation Therapy.

Advances in radiation oncology

Chan MF, Young C, Gelblum D, Shi C, Rincon C, Hipp E, Li J, Wang D.
PMID: 34409216
Adv Radiat Oncol. 2021 Aug 06;6(4):100732. doi: 10.1016/j.adro.2021.100732. eCollection 2021.

PURPOSE: This review article aims to consolidate information regarding existing and emerging implanted devices used in patients undergoing radiation therapy and to categorize levels of attention needed for each device, including which devices require monitoring throughout treatment.METHODS AND MATERIALS:...

Cite
Chan MF, Young C, Gelblum D, et al. A Review and Analysis of Managing Commonly Seen Implanted Devices for Patients Undergoing Radiation Therapy. Adv Radiat Oncol. 2021;6(4):100732doi: 10.1016/j.adro.2021.100732.
Chan, M. F., Young, C., Gelblum, D., Shi, C., Rincon, C., Hipp, E., Li, J., & Wang, D. (2021). A Review and Analysis of Managing Commonly Seen Implanted Devices for Patients Undergoing Radiation Therapy. Advances in radiation oncology, 6(4), 100732. https://doi.org/10.1016/j.adro.2021.100732
Chan, Maria F, et al. "A Review and Analysis of Managing Commonly Seen Implanted Devices for Patients Undergoing Radiation Therapy." Advances in radiation oncology vol. 6,4 (2021): 100732. doi: https://doi.org/10.1016/j.adro.2021.100732
Chan MF, Young C, Gelblum D, Shi C, Rincon C, Hipp E, Li J, Wang D. A Review and Analysis of Managing Commonly Seen Implanted Devices for Patients Undergoing Radiation Therapy. Adv Radiat Oncol. 2021 Aug 06;6(4):100732. doi: 10.1016/j.adro.2021.100732. eCollection 2021. PMID: 34409216; PMCID: PMC8361059.
Copy Download .nbib Format: NLM
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

JAMA network open

Li X, Kitpanit S, Lee A, Mah D, Sine K, Sherman EJ, Dunn LA, Michel LS, Fetten J, Zakeri K, Yu Y, Chen L, Kang JJ, Gelblum DY, McBride SM, Tsai CJ, Riaz N, Lee NY.
PMID: 34143193
JAMA Netw Open. 2021 Jun 01;4(6):e2113205. doi: 10.1001/jamanetworkopen.2021.13205.

IMPORTANCE: Patients with nonmetastatic nasopharyngeal carcinoma (NPC) are primarily treated by radiotherapy with curative intent with or without chemotherapy and often experience substantial treatment-related toxic effects even with modern radiation techniques, such as intensity-modulated radiation therapy (IMRT). Intensity-modulated proton...

Cite
Li X, Kitpanit S, Lee A, et al. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA Netw Open. 2021;4(6):e2113205doi: 10.1001/jamanetworkopen.2021.13205.
Li, X., Kitpanit, S., Lee, A., Mah, D., Sine, K., Sherman, E. J., Dunn, L. A., Michel, L. S., Fetten, J., Zakeri, K., Yu, Y., Chen, L., Kang, J. J., Gelblum, D. Y., McBride, S. M., Tsai, C. J., Riaz, N., & Lee, N. Y. (2021). Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA network open, 4(6), e2113205. https://doi.org/10.1001/jamanetworkopen.2021.13205
Li, Xingzhe, et al. "Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy." JAMA network open vol. 4,6 (2021): e2113205. doi: https://doi.org/10.1001/jamanetworkopen.2021.13205
Li X, Kitpanit S, Lee A, Mah D, Sine K, Sherman EJ, Dunn LA, Michel LS, Fetten J, Zakeri K, Yu Y, Chen L, Kang JJ, Gelblum DY, McBride SM, Tsai CJ, Riaz N, Lee NY. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA Netw Open. 2021 Jun 01;4(6):e2113205. doi: 10.1001/jamanetworkopen.2021.13205. PMID: 34143193; PMCID: PMC8214161.
Copy Download .nbib Format: NLM
Aqueous Suzuki Coupling Reactions of Basic Nitrogen-Containing Substrates in the Absence of Added Base and Ligand: Observation of High Yields under Acidic Conditions.

The Journal of organic chemistry

Li Z, Gelbaum C, Fisk JS, Holden B, Jaganathan A, Whiteker GT, Pollet P, Liotta CL.
PMID: 27559749
J Org Chem. 2016 Sep 16;81(18):8520-9. doi: 10.1021/acs.joc.6b01683. Epub 2016 Sep 01.

A series of aqueous heterogeneous Suzuki coupling reactions of substrates containing basic nitrogen centers with phenylboronic acid in the absence of added base and ligand is presented. High yields of products were obtained by employing aryl bromides containing aliphatic...

Cite
Li Z, Gelbaum C, Fisk JS, et al. Aqueous Suzuki Coupling Reactions of Basic Nitrogen-Containing Substrates in the Absence of Added Base and Ligand: Observation of High Yields under Acidic Conditions. J Org Chem. 2016;81(18):8520-9doi: 10.1021/acs.joc.6b01683.
Li, Z., Gelbaum, C., Fisk, J. S., Holden, B., Jaganathan, A., Whiteker, G. T., Pollet, P., & Liotta, C. L. (2016). Aqueous Suzuki Coupling Reactions of Basic Nitrogen-Containing Substrates in the Absence of Added Base and Ligand: Observation of High Yields under Acidic Conditions. The Journal of organic chemistry, 81(18), 8520-9. https://doi.org/10.1021/acs.joc.6b01683
Li, Zhao, et al. "Aqueous Suzuki Coupling Reactions of Basic Nitrogen-Containing Substrates in the Absence of Added Base and Ligand: Observation of High Yields under Acidic Conditions." The Journal of organic chemistry vol. 81,18 (2016): 8520-9. doi: https://doi.org/10.1021/acs.joc.6b01683
Li Z, Gelbaum C, Fisk JS, Holden B, Jaganathan A, Whiteker GT, Pollet P, Liotta CL. Aqueous Suzuki Coupling Reactions of Basic Nitrogen-Containing Substrates in the Absence of Added Base and Ligand: Observation of High Yields under Acidic Conditions. J Org Chem. 2016 Sep 16;81(18):8520-9. doi: 10.1021/acs.joc.6b01683. Epub 2016 Sep 01. PMID: 27559749.
Copy Download .nbib Format: NLM
Evolution of the Intracranial Approaches to Jugular Foramen Tumors: A Surgeon's Personal Perspective Through Three Illustrative Cases.

Cureus

Jean WC, Felbaum D.
PMID: 27081591
Cureus. 2016 Mar 12;8(3):e530. doi: 10.7759/cureus.530.

Tumors of the jugular foramen remain challenging lesions despite advances in surgical technique and medical technology. Tumors with extensive extra- and intracranial components necessitate both radical neck dissection maneuvers combined with skull base approaches. We present a single surgeon's...

Cite
Jean WC, Felbaum D. Evolution of the Intracranial Approaches to Jugular Foramen Tumors: A Surgeon's Personal Perspective Through Three Illustrative Cases. Cureus. 2016;8(3):e530doi: 10.7759/cureus.530.
Jean, W. C., & Felbaum, D. (2016). Evolution of the Intracranial Approaches to Jugular Foramen Tumors: A Surgeon's Personal Perspective Through Three Illustrative Cases. Cureus, 8(3), e530. https://doi.org/10.7759/cureus.530
Jean, Walter C, and Felbaum, Daniel. "Evolution of the Intracranial Approaches to Jugular Foramen Tumors: A Surgeon's Personal Perspective Through Three Illustrative Cases." Cureus vol. 8,3 (2016): e530. doi: https://doi.org/10.7759/cureus.530
Jean WC, Felbaum D. Evolution of the Intracranial Approaches to Jugular Foramen Tumors: A Surgeon's Personal Perspective Through Three Illustrative Cases. Cureus. 2016 Mar 12;8(3):e530. doi: 10.7759/cureus.530. PMID: 27081591; PMCID: PMC4829410.
Copy Download .nbib Format: NLM
Identifying multiscale spatio-temporal patterns in human mobility using manifold learning.

PeerJ. Computer science

Watson JR, Gelbaum Z, Titus M, Zoch G, Wrathall D.
PMID: 33816927
PeerJ Comput Sci. 2020 Jun 15;6:e276. doi: 10.7717/peerj-cs.276. eCollection 2020.

When, where and how people move is a fundamental part of how human societies organize around every-day needs as well as how people adapt to risks, such as economic scarcity or instability, and natural disasters. Our ability to characterize...

Cite
Watson JR, Gelbaum Z, Titus M, et al. Identifying multiscale spatio-temporal patterns in human mobility using manifold learning. PeerJ Comput Sci. 2020;6:e276doi: 10.7717/peerj-cs.276.
Watson, J. R., Gelbaum, Z., Titus, M., Zoch, G., & Wrathall, D. (2020). Identifying multiscale spatio-temporal patterns in human mobility using manifold learning. PeerJ. Computer science, 6e276. https://doi.org/10.7717/peerj-cs.276
Watson, James R, et al. "Identifying multiscale spatio-temporal patterns in human mobility using manifold learning." PeerJ. Computer science vol. 6 (2020): e276. doi: https://doi.org/10.7717/peerj-cs.276
Watson JR, Gelbaum Z, Titus M, Zoch G, Wrathall D. Identifying multiscale spatio-temporal patterns in human mobility using manifold learning. PeerJ Comput Sci. 2020 Jun 15;6:e276. doi: 10.7717/peerj-cs.276. eCollection 2020. PMID: 33816927; PMCID: PMC7924485.
Copy Download .nbib Format: NLM
Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate alzheimer's disease.

Neuropsychiatric disease and treatment

Maynard SD, Gelblum J.
PMID: 24187497
Neuropsychiatr Dis Treat. 2013;9:1619-27. doi: 10.2147/NDT.S52331. Epub 2013 Oct 23.

BACKGROUND: The purpose of this study was to evaluate the effects of caprylic triglyceride (CT) in patients with mild-to-moderate Alzheimer's disease (AD) in routine clinical practice via review of medical records and caregiver questionnaires.METHODS: Participants were outpatients aged ≥50...

Cite
Maynard SD, Gelblum J. Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate alzheimer's disease. Neuropsychiatr Dis Treat. 2013;9:1619-27doi: 10.2147/NDT.S52331.
Maynard, S. D., & Gelblum, J. (2013). Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate alzheimer's disease. Neuropsychiatric disease and treatment, 91619-27. https://doi.org/10.2147/NDT.S52331
Maynard, Steven Douglas, and Gelblum, Jeff. "Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate alzheimer's disease." Neuropsychiatric disease and treatment vol. 9 (2013): 1619-27. doi: https://doi.org/10.2147/NDT.S52331
Maynard SD, Gelblum J. Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate alzheimer's disease. Neuropsychiatr Dis Treat. 2013;9:1619-27. doi: 10.2147/NDT.S52331. Epub 2013 Oct 23. PMID: 24187497; PMCID: PMC3810439.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries